HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michel Beaugrand Selected Research

Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)

8/2013Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.
12/2012Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.
10/2012Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma.
7/2011Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
11/2009Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
1/2008Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
5/2007Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
3/2006Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.
3/2005Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michel Beaugrand Research Topics

Disease

37Hepatocellular Carcinoma (Hepatoma)
01/2016 - 06/2002
36Fibrosis (Cirrhosis)
01/2016 - 12/2002
14Neoplasms (Cancer)
01/2016 - 01/2005
9Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
08/2013 - 03/2005
5Liver Diseases (Liver Disease)
10/2014 - 05/2007
5Hepatitis C
08/2012 - 11/2007
4Liver Cirrhosis (Hepatic Cirrhosis)
10/2012 - 01/2005
3Necrosis
04/2013 - 01/2005
2Carcinogenesis
08/2013 - 07/2010
2Hepatitis
01/2013 - 12/2010
2Insulin Resistance
08/2011 - 11/2010
2Cholestasis
08/2009 - 07/2008
2Infections
03/2009 - 05/2007
2Iron Overload
01/2008 - 05/2007
2Chronic Hepatitis C
01/2005 - 10/2004
1Liver Failure
04/2014
1Liver Abscess
04/2013
1Wounds and Injuries (Trauma)
04/2013
1Prostatic Neoplasms (Prostate Cancer)
01/2013
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
10/2012
1Non-alcoholic Fatty Liver Disease
03/2012
1Type 2 Diabetes Mellitus (MODY)
08/2011
1Hemochromatosis (Bronze Diabetes)
07/2011
1End Stage Liver Disease
07/2011
1Bone Marrow Failure Disorders
05/2011
1Fatty Liver
11/2010
1Persistent Infection
11/2010
1Obesity
11/2010
1Injection Site Reaction
05/2010
1Chronic Hepatitis B
03/2009

Drug/Important Bio-Agent (IBA)

5IronIBA
07/2011 - 03/2006
4Ethanol (Ethyl Alcohol)IBA
11/2006 - 12/2002
3F 4 (F-4)IBA
11/2015 - 02/2006
3Biomarkers (Surrogate Marker)IBA
12/2013 - 08/2007
3AntioxidantsIBA
08/2012 - 03/2006
3Peroxidase (Myeloperoxidase)IBA
02/2012 - 11/2009
3ChemokinesIBA
07/2011 - 05/2007
3Chemokine CCL5IBA
07/2011 - 05/2007
3EnzymesIBA
07/2011 - 03/2006
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2009 - 08/2007
3Superoxide DismutaseIBA
11/2008 - 03/2005
3Antiviral Agents (Antivirals)IBA
11/2007 - 02/2005
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2013 - 08/2009
2Keratins (Keratin)IBA
10/2012 - 07/2010
2Insulin-Like PeptidesIBA
08/2012 - 09/2008
2Biological ProductsIBA
07/2011 - 12/2006
2superoxide dismutase 2IBA
07/2011 - 11/2009
2Telomerase (Telomerase Reverse Transcriptase)IBA
05/2011 - 05/2010
2Genetic Markers (Genetic Marker)IBA
02/2008 - 05/2007
2Chemokine ReceptorsIBA
02/2008 - 05/2007
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2008 - 05/2007
1Fetal Proteins (Fetoprotein)IBA
10/2014
1Interleukin-6 (Interleukin 6)IBA
08/2014
1CytokinesIBA
08/2014
1Epithelial Cell Adhesion MoleculeIBA
12/2013
1CateninsIBA
12/2013
1Syndecan-1 (Syndecan 1)IBA
08/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013
1Proteoglycans (Proteoglycan)IBA
08/2013
1GlypicansIBA
08/2013
1Cyproterone AcetateIBA
01/2013
1AndrogensIBA
01/2013
1Glycoproteins (Glycoprotein)IBA
12/2012
1Glutamic Acid (Glutamate)FDA Link
12/2012
1Acetates (Acetic Acid Esters)FDA Link
12/2012
1Protons (Proton)IBA
12/2012
1Glutamine (L-Glutamine)FDA Link
12/2012
1LipidsIBA
12/2012
1K-18 conjugate (K18)IBA
10/2012
1Keratin-8 (Keratin 8)IBA
10/2012
1Sorafenib (BAY 43-9006)FDA Link
10/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1sodium bisulfiteFDA Link
08/2012
1Propranolol (Inderal)FDA LinkGeneric
08/2012
1Metformin (Glucophage)FDA LinkGeneric
08/2011
1alanylprolineIBA
07/2011
1telomerase RNA (bTR)IBA
05/2011
1Levonorgestrel (Plan B)FDA LinkGeneric
12/2010
1Oral ContraceptivesIBA
12/2010
1LeptinIBA
11/2010
1AdiponectinIBA
11/2010
1A-factor (Streptomyces)IBA
11/2010
1thiamine triphosphorate (TTP)IBA
05/2010
1Peptides (Polypeptides)IBA
05/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2010
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2010
1CollagenIBA
11/2009
1Prothrombin (Factor II)IBA
11/2009
1Lamivudine (Epivir)FDA Link
03/2009
1adefovir dipivoxil (Hepsera)FDA Link
03/2009
1lipoarabinomannan (LAM)IBA
03/2009
1Adenosine Triphosphate (ATP)IBA
07/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2008

Therapy/Procedure

13Radiofrequency Ablation
01/2016 - 07/2005
8Therapeutics
10/2012 - 01/2005
4Liver Transplantation
04/2014 - 11/2005
4Transplantation
01/2012 - 06/2002
2Electrodes (Electrode)
01/2016 - 05/2008
1Sphincterotomy
04/2013
1Contraindications
08/2011